» Articles » PMID: 27493146

Evolutionary Genomics of Yeast Pathogens in the Saccharomycotina

Overview
Journal FEMS Yeast Res
Specialty Microbiology
Date 2016 Aug 6
PMID 27493146
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Saccharomycotina comprises a diverse group of yeasts that includes numerous species of industrial or clinical relevance. Opportunistic pathogens within this clade are often assigned to the genus Candida but belong to phylogenetically distant lineages that also comprise non-pathogenic species. This indicates that the ability to infect humans has evolved independently several times among Saccharomycotina. Although the mechanisms of infection of the main groups of Candida pathogens are starting to be unveiled, we still lack sufficient understanding of the evolutionary paths that led to a virulent phenotype in each of the pathogenic lineages. Deciphering what genomic changes underlie the evolutionary emergence of a virulence trait will not only aid the discovery of novel virulence mechanisms but it will also provide valuable information to understand how new pathogens emerge, and what clades may pose a future danger. Here we review recent comparative genomics efforts that have revealed possible evolutionary paths to pathogenesis in different lineages, focusing on the main three agents of candidiasis worldwide: Candida albicans, C. parapsilosis and C. glabrata We will discuss what genomic traits may facilitate the emergence of virulence, and focus on two different genome evolution mechanisms able to generate drastic phenotypic changes and which have been associated to the emergence of virulence: gene family expansion and interspecies hybridization.

Citing Articles

Humanized Candida and NanoBiT Assays Expedite Discovery of Bdf1 Bromodomain Inhibitors With Antifungal Potential.

Wei K, Arlotto M, Overhulse J, Dinh T, Zhou Y, Dupper N Adv Sci (Weinh). 2025; 12(10):e2404260.

PMID: 39821709 PMC: 11904993. DOI: 10.1002/advs.202404260.


Threats from the complex: the surge of multidrug resistance and a hotbed for new emerging pathogens.

Gabaldon T Microbiol Mol Biol Rev. 2024; 88(4):e0002923.

PMID: 39508581 PMC: 11653726. DOI: 10.1128/mmbr.00029-23.


Long-term stability of acquired drug resistance and resistance associated mutations in the fungal pathogen ().

Ksiezopolska E, Schikora-Tamarit M, Carlos Nunez-Rodriguez J, Gabaldon T Front Cell Infect Microbiol. 2024; 14:1416509.

PMID: 39077431 PMC: 11284152. DOI: 10.3389/fcimb.2024.1416509.


Assessing Diagnosis of Infections: A Study on Species Prevalence and Antifungal Resistance in Northern Morocco.

Ahaik I, Carlos Nunez-Rodriguez J, Abrini J, Bouhdid S, Gabaldon T J Fungi (Basel). 2024; 10(6).

PMID: 38921360 PMC: 11204772. DOI: 10.3390/jof10060373.


A genome-informed higher rank classification of the biotechnologically important fungal subphylum .

Groenewald M, Hittinger C, Bensch K, Opulente D, Shen X, Li Y Stud Mycol. 2024; 105:1-22.

PMID: 38895705 PMC: 11182611. DOI: 10.3114/sim.2023.105.01.


References
1.
Gabaldon T . Comparative genomics-based prediction of protein function. Methods Mol Biol. 2008; 439:387-401. DOI: 10.1007/978-1-59745-188-8_26. View

2.
Hawksworth D . Managing and coping with names of pleomorphic fungi in a period of transition. IMA Fungus. 2012; 3(1):15-24. PMC: 3399099. DOI: 10.5598/imafungus.2012.03.01.03. View

3.
Forche A . Large-Scale Chromosomal Changes and Associated Fitness Consequences in Pathogenic Fungi. Curr Fungal Infect Rep. 2015; 8(2):163-170. PMC: 4326016. DOI: 10.1007/s12281-014-0181-2. View

4.
Tavanti A, Davidson A, Gow N, Maiden M, Odds F . Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol. 2005; 43(1):284-92. PMC: 540126. DOI: 10.1128/JCM.43.1.284-292.2005. View

5.
Pfaller M, Diekema D . Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007; 20(1):133-63. PMC: 1797637. DOI: 10.1128/CMR.00029-06. View